ISIN | LU2204946912 |
---|---|
Valor Number | 55896852 |
Bloomberg Global ID | MUFOHUQ LX |
Fund Name | Multi Manager Access II - Future of Humans USD Q-acc |
Fund Provider |
UBS Switzerland AG, Zurich
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Other Funds |
EFC Category | Equity Global |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | The investment objective of the actively managed sub-fund is to seek long-term real returns. No guarantee can be given that this investment objective will be achieved. The sub-fund is categorized as an ESG Integrated Fund. However, the sub-fund does not promote particular ESG characteristics or pursue a specific sustainability or impact objective. The investments underlying this financial product do not take into account the EU criteria for environmentally sustainable economic activities. |
Peculiarities |
Current Price * | 100.92 USD | 31.10.2024 |
---|---|---|
Previous Price * | 101.66 USD | 30.10.2024 |
52 Week High * | 102.85 USD | 30.09.2024 |
52 Week Low * | 84.13 USD | 02.11.2023 |
NAV * | 100.92 USD | 31.10.2024 |
Issue Price * | 100.92 USD | 31.10.2024 |
Redemption Price * | 100.92 USD | 31.10.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 55,849,582 | |
Unit/Share Assets *** | 17,360,263 | |
Trading Information SIX |
YTD Performance | +7.44% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
YTD Performance (in CHF) | +10.28% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
1 month | -1.88% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 months | +2.53% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 months | +8.18% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 year | +22.45% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 years | +22.85% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 years | -14.63% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 years | +0.92% |
19.10.2020 - 31.10.2024
19.10.2020 31.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UnitedHealth Group Inc | 2.53% | |
---|---|---|
Novo Nordisk AS Class B | 2.27% | |
Boston Scientific Corp | 2.24% | |
Danaher Corp | 2.17% | |
Amazon.com Inc | 2.02% | |
Booking Holdings Inc | 2.02% | |
Meta Platforms Inc Class A | 1.97% | |
Netflix Inc | 1.96% | |
Eli Lilly and Co | 1.96% | |
Bristol-Myers Squibb Co | 1.88% | |
Last data update | 31.10.2024 |
TER | 1.03% |
---|---|
TER date | 31.07.2023 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.77% |
Ongoing Charges *** | 1.00% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |